Use of nonsteroidal anti-inflammatory drugs in case of ankylosing spondylitis: Long and persistently!

Use of nonsteroidal anti-inflammatory drugs in case of ankylosing spondylitis: Long and persistently!

Nonsteroidal anti-inflammatory drugs (NSAIDs) are extensively used in the treatment of rheumatic diseases to relieve pain and signs of inflammation. However, when treated for ankylosing spondylosis (AS), NSAIDS exert both symptomatic and structure-modifying effects, by slowing down the development o...

Full description

Bibliographic Details
Main Authors:	A E Karateev, Sh F Érdes
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2014-11-01
Series:	Терапевтический архив
Subjects:	ankylosing spondylitis nonsteroidal anti-inflammatory drugs structure-modifying activity
Online Access:	https://ter-arkhiv.ru/0040-3660/article/view/31665

Similar Items

Choice of a nonsteroidal anti-inflammatory drug in ankylosing spondylitis
by: Rimma Mikhailovna Balabanova, et al.
Published: (2014-12-01)

Nonsteroidal anti-inflammatory drugs: a basis for the treatment of ankylosing spondylitis
by: A A Godzenko
Published: (2011-12-01)

Problems of prescribing nonsteroidal anti-inflammatory drugs for reproductive-aged women with ankylosing spondylitis
by: O. A. Krichevskaya, et al.
Published: (2020-09-01)

Biomarkers of bone remodeling in ankylosing spondylitis patients using nonsteroidal anti-inflammatory drugs: results of an ETHICS research program
by: I Z Gaydukova, et al.
Published: (2017-12-01)

EFFICIENCY OF ANTI-INFLAMMATORY THERAPY IN PATIENTS WITH ANKYLOSING SPONDYLITIS ACCORDING TO THE RESULTS OF A PROSPECTIVE FOLLOW-UP STUDY
by: T. A. Raskina, et al.
Published: (2016-09-01)

Prospects for the use of celecoxib in patients with ankylosing spondylitis: impact on retarding disease progression
by: Yulia Leonidovna Korsakova
Published: (2012-09-01)

Non-Steroidal Anti-Inflammatory Drug Etoricoxib Facilitates the Application of Individualized Exercise Programs in Patients with Ankylosing Spondylitis
by: Iulia Rahela Marcu, et al.
Published: (2020-05-01)

Vessel wall stiffness in ankylosing spondylitis patients taking nonsteroidal anti-inflammatory drugs
by: I. Z. Gaidukova, et al.
Published: (2016-09-01)

USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS, MONITORING THEIR EFFICACY AND SAFETY (DRAFT GUIDELINES OF THE EXPERT SPONDYLOARTHRITIS DIAGNOSIS AND TREATMENT GROUP)
by: I. Z. Gaidukova, et al.
Published: (2016-09-01)

Treatment of ankylosing spondylitis during pregnancy
by: O. A. Krichevskaya, et al.
Published: (2021-07-01)

Have nonsteroidal anti-inflammatory drugs a pathogenetic action?
by: Andrei Evgenyevich Karateev
Published: (2012-12-01)

Have nonsteroidal anti-inflammatory drugs a pathogenetic action?
by: Andrei Evgenyevich Karateev
Published: (2012-12-01)

Brazilian recommendations for the use of nonsteroidal anti-inflammatory drugs in patients with axial spondyloarthritis
by: Ricardo da Cruz Lage, et al.
Published: (2021-01-01)

TREATMENT IN PATIENTS WITH ANKYLOSING SPONDYLITIS IN THE REAL CLINICAL PRACTICE OF A RHEUMATOLOGIST IN RUSSIA
by: Sh F Erdes, et al.
Published: (2013-02-01)

Different effects of anti-TNF-alpha biologic drugs on the small bowel macroscopic inflammation in patients with ankylosing spondylitis
by: Chitul A., et al.
Published: (2017-03-01)

Efficiency and safety of different etoricoxib regimens in patients with axial spondyloarthritis, including ankylosing spondylitis
by: I Z Gaydukova, et al.
Published: (2015-03-01)

Symptom modifiers in therapy for ankylosing spondylitis
by: V. V. Badokin
Published: (2010-06-01)

Recent advances and prospects of axial spondyloarthritis / ankylosing spondylitis treatment
by: Sh. F. Erdes
Published: (2021-04-01)

OSTEOPOROSIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Elena Efimovna Gubar, et al.
Published: (2013-12-01)

Efficacy and Safety of Celecoxib in Chinese Patients with Ankylosing Spondylitis: A 6-Week Randomized, Double-Blinded Study with 6-Week Open-Label Extension Treatment
by: Feng Huang, MD, et al.
Published: (2014-12-01)

Some aspects of pathogenesis of ankylosing spondylitis
by: Shandor Erdes, et al.
Published: (2011-05-01)

Symptomatic therapy for ankylosing spondylitis
by: Vladimir Vasilyevich Badokin
Published: (2012-03-01)

Symptomatic therapy for ankylosing spondylitis
by: Vladimir Vasilyevich Badokin
Published: (2012-03-01)

Extraskeletal manifestations and the indicators of inflammatory activity and severity in ankylosing spondylitis
by: A. A. Godzenko, et al.
Published: (2018-04-01)

SIGNIFICANCE OF PERIPHERAL ARTHRITIS IN ANKYLOSING SPONDYLITIS
by: Sh. F. Erdes, et al.
Published: (2014-06-01)

Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs
by: F.M. Perrotta, et al.
Published: (2014-11-01)

Reasons for late diagnosis of ankylosing spondylitis in clinical practice
by: Tatyana Vasilyevna Dubinina, et al.
Published: (2010-04-01)

CHARACTERISTICS OF ADMINISTRATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN ANKYLOSING SPONDYLITIS: CLINICAL OBSERVATION
by: N. A. Shostak, et al.
Published: (2018-06-01)

Spine inflammatory changes in patients with ankylosing spondylitis assessed by magnetic resonance image
by: A G Bochkova, et al.
Published: (2008-10-01)

EXPERIENCE WITH RITUXIMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Mikhail Sergeyevich Protopopov, et al.
Published: (2013-02-01)

Evaluation of efficacy and safety of long-term use of amtolmetin guacil in rheumatic diseases: results of a 9-month observational AURORA study (Amtolmetin guacil: allRussian Register for Osteoarthritis, Rheumatoid arthritis and Ankylosing spondylitis)
by: A. E. Karateev, et al.
Published: (2019-03-01)

HISTORY OF ANKYLOSING SPONDYLITIS: THE JOURNEY FROM DINOSAURS TO ASAS
by: Shandor F Erdes
Published: (2014-03-01)

COURSE OF UVEITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: A. A. Godzenko, et al.
Published: (2016-09-01)

DIAGNOSIS AND TREATMENT OF COXITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: E. M. Agafonova, et al.
Published: (2018-09-01)

THE NEED AND POSSIBILITIES OF EARLY DIAGNOSIS OF ANKYLOSING SPONDYLITIS: COMMENTARIES ON THE PAPER «EARLY DIAGNOSIS OF ANKYLOSING SPONDYLITIS» (No. 4, 2013) AND DISCUSSION IN THE JOURNAL (No. 2, 2014)
by: Sh. F. Erdes
Published: (2014-09-01)

CHANGE OF ACTIVITY, FUNCTIONAL CLASS, AND SPINAL MOBILITY IN ANKYLOSING SPONDYLOSIS DURING THERAPY WITH DIFFERENT PHARMACOLOGICAL AGENTS
by: M. Ivanova, et al.
Published: (2014-06-01)

INTERLEUKIN-17A IS A NEW TARGET OF ANTICYTOKINE THERAPY FOR ANKYLOSING SPONDYLITIS
by: Sh. F. Erdes
Published: (2016-09-01)

THE FREQUENCY AND SEVERITY OF EXTRASKELETAL MANIFESTATIONS OF ANKYLOSING SPONDYLITIS
by: A. A. Godzenko, et al.
Published: (2017-04-01)

Nonsteroidal anti-inflammatory drugs: What is new in international publications in 2015?
by: A. E. Karateev, et al.
Published: (2016-03-01)

Ankylosing Spondylitis
by: Nazanin Ebrahimiadib, et al.
Published: (2021-07-01)